HilleVax, Inc.(HLVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HLVX HilleVax, Inc.

Market Closed 03-28 16:00:00 EDT

1.59

-0.02

-1.24%

盘后1.59

+0.000.00%

17:37 EDT

High1.71	Low1.58	Vol92.56K
Open1.61	D1 Closing1.61	Amplitude8.07%
Mkt Cap76.69M	Tradable Cap46.17M	Total Shares48.23M
T/O148.29K	T/O Rate0.32%	Tradable Shares29.04M
P/B0.50	ROE-70.13%	EPS-3.09
52wk High16.66	52wk Low1.55	P/E-0.51
Dividend0.00	Div.Yield0.00	ROA-24.89%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"HLVX","market":"US","secType":"STK","nameCN":"HilleVax, Inc.","latestPrice":1.59,"timestamp":1743192000000,"preClose":1.61,"halted":0,"volume":92564,"hourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.59,"latestTime":"17:37 EDT","volume":9513,"amount":15051.19,"timestamp":1743197864410},"delay":0,"floatShares":29040351,"shares":48234354,"eps":-3.088037,"marketStatus":"Market Closed","change":-0.02,"latestTime":"03-28 16:00:00 EDT","open":1.61,"high":1.71,"low":1.58,"amount":148287.528,"amplitude":0.080745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.088037,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":7,"adr":0,"listingDate":1651204800000,"exchange":"NASDAQ","adjPreClose":1.61,"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.59,"latestTime":"17:37 EDT","volume":9513,"amount":15051.19,"timestamp":1743197864410},"volumeRatio":0.5993468571610032},"requestUrl":"/m/hq/s/HLVX","defaultTab":"news","newsList":[{"id":"2523635621","title":"BRIEF-Hillevax Q4 Net Income USD -33.947 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635621","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635621?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:00","pubTimestamp":1743195645,"startTime":"0","endTime":"0","summary":"BRIEF-Hillevax Q4 Net Income USD -33.947 Million\n\n\nMar 28 (Reuters) - Hillevax Q4 basic EPS USD -0.68.\n\nQ4 operating income USD -36.151 million\nQ4 operating expenses USD 36.151 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLX70C5F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2523635806","title":"Hillevax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635806?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:00","pubTimestamp":1743195600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA6PVSWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2523635808","title":"Hillevax Q4 Basic EPS USD -0.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635808?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:00","pubTimestamp":1743195600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLX70C5F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLVX","BK4139"],"gpt_icon":0},{"id":"2523635549","title":"Press Release: HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635549?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:00","pubTimestamp":1743195600,"startTime":"0","endTime":"0","summary":"$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024. The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activities and other strategic alternatives. BOSTON, March 28, 2025  -- HilleVax, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the year ended December 31, 2024.Research and development expenses for the fourth quarter 2024 were $9.2 million and $78.2 million for the full year ended December 31, 2024, compared to $33.3 for the fourth quarter 2023 and $106.7 million for the full year ended December 31, 2023. The decrease was primarily due to lower clinical development costs.Other income for the fourth quarter 2024 was $2.2 million and $8.0 for the full year ended December 31 2024, compared to $3.3 million for the fourth quarter 2023 and $9.8 million fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLVX","LU2065732104.USD","BK4139","PRGS","BK4097","VLP"],"gpt_icon":0},{"id":"2490474054","title":"3 US Penny Stocks With Market Caps Under $100M","url":"https://stock-news.laohu8.com/highlight/detail?id=2490474054","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490474054?lang=en_us&edition=full_marsco","pubTime":"2024-12-10 04:04","pubTimestamp":1733774689,"startTime":"0","endTime":"0","summary":"As U.S. stocks experience fluctuations amid anticipation of key inflation data and interest rate decisions, investors are keenly observing market movements for potential opportunities. Penny stocks, a term that may seem outdated, continue to capture attention due to their affordability and growth potential, particularly when backed by strong financials. These smaller or newer companies can offer unique value propositions that larger firms might overlook, making them intriguing options for...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cycn/cyclerion-therapeutics/news/3-us-penny-stocks-with-market-caps-under-100m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PVL","BK4551","HLVX","BK4209","BK4213","BK4075","BABB","BK4139","RLX","BK4526","BK4563"],"gpt_icon":0},{"id":"2489371289","title":"BUZZ-HilleVax rises after disclosing plan to lay off 70% of employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2489371289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489371289?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 20:02","pubTimestamp":1733486555,"startTime":"0","endTime":"0","summary":"** Shares of vaccine developer HilleVax    rise ~14% to $2.13 premarket   ** HLVX to lay of about 28 employees, or about 70% of its workforce, to reduce operating costs, co said on Thursday    ** Co says remaining team will focus on developing norovirus vaccine candidates, HIL-214 and HIL-216   ** Co estimates that it will incur charges associated with the workforce reduction of about $6.1 mln    ** As of Dec. 31, 2023, HLVX had 90 full-time employees - SEC filling   ** Earlier this year, HLVX laid off about 41 employees   ** As of last close, stock has fallen 88.4% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2489443678","title":"HilleVax Shares Rise After Announcing Job Cuts, Executive Departures","url":"https://stock-news.laohu8.com/highlight/detail?id=2489443678","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489443678?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 07:41","pubTimestamp":1733442060,"startTime":"0","endTime":"0","summary":"Shares of HilleVax gained after it said it will cut about 70% of its workforce, or about 28 jobs, and that several executives were leaving the company.The stock jumped 16%, to $2.16, in after-hours trading Thursday. Shares ended the day 2.6% lower, at $1.87, putting them down 88% since the beginning of the year.The Boston-based biopharmaceutical company said its job cuts, which are likely to be substantially complete by the end of January, will reduce operating expenses. It previously cut 15 jobs, or about 25% of its workforce, in October.It expects to incur about $6.1 million in charges associated with the current round of layoffs, primarily from employee severance payments, benefits and related termination costs. The majority of these charges will be recognized in the fourth quarter of this year, the company said.HilleVax's remaining workers will continue to explore and evaluate the development of its norovirus vaccine candidates, as well as business development-related activities fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2489841621","title":"HilleVax, Inc. Announces Workforce Reduction and Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2489841621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489841621?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 05:33","pubTimestamp":1733434414,"startTime":"0","endTime":"0","summary":"HilleVax, Inc ( ($HLVX) ) just unveiled an announcement. HilleVax, Inc. is reducing its workforce by 70% to cut costs while continuing to pursue th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hillevax-inc-announces-workforce-reduction-and-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hillevax-inc-announces-workforce-reduction-and-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HLVX","BK4139"],"gpt_icon":0},{"id":"2489241579","title":"On December 4, 2024, Hillevax Commenced A Workforce Reduction Of 28 Employees, Constituting ~70% Of The Company's Workforce; Estimates That It Will Incur Charges Associated With The Workforce Reduction Of ~$6.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2489241579","media":"Benzinga","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489241579?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 05:28","pubTimestamp":1733434103,"startTime":"0","endTime":"0","summary":"On December 4, 2024, HilleVax, Inc. (the &#34;Company&#34;) commenced a workforce reduction of 28 employees, constituting approximately 70% of the Company&#39;s workforce, to reduce its operating expenses. The Company&#39;s remaining","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42351977/on-december-4-2024-hillevax-commenced-a-workforce-reduction-of-28-employees-constituting-70-of-the-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"On December 4, 2024, Hillevax Commenced A Workforce Reduction Of 28 Employees, Constituting ~70% Of The Company's Workforce; Estimates That It Will Incur Charges Associated With The Workforce Reduction Of ~$6.1M","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLVX","BK4139"],"gpt_icon":0},{"id":"2489154894","title":"Hillevax Inc - Commences Workforce Reduction of 28 Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2489154894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489154894?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 05:25","pubTimestamp":1733433959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nFWN3N60GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2481341904","title":"HilleVax Q3 EPS $(0.52) Misses $(0.42) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481341904","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481341904?lang=en_us&edition=full_marsco","pubTime":"2024-11-07 21:07","pubTimestamp":1730984851,"startTime":"0","endTime":"0","summary":"HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.42) by 23.81 percent. This is a 35.8 percent increase over losses of $(0.81) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41805441/hillevax-q3-eps-0-52-misses-0-42-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HilleVax Q3 EPS $(0.52) Misses $(0.42) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLVX"],"gpt_icon":0},{"id":"2481012989","title":"Hillevax Q3 Basic EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2481012989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481012989?lang=en_us&edition=full_marsco","pubTime":"2024-11-07 21:00","pubTimestamp":1730984401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nPLXD1CA9B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLVX","BK4139"],"gpt_icon":0},{"id":"2481901796","title":"Press Release: HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2481901796","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481901796?lang=en_us&edition=full_marsco","pubTime":"2024-11-07 21:00","pubTimestamp":1730984400,"startTime":"0","endTime":"0","summary":"$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024. The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activities and other strategic alternatives. BOSTON, Nov. 07, 2024  -- HilleVax, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended September 30, 2024.Research and development expenses for the third quarter 2024 were $20.2 million, compared to $27.3 for the third quarter 2023. The decrease was primarily due to lower clinical development costs.The Company cautions you that statements contained in this report regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on the Company's current beliefs and expectations and include, but are not limited to: the timing and scope of a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VLP","PRGS","BK4139","LU2065732104.USD","BK4097","HLVX"],"gpt_icon":0},{"id":"2481963350","title":"Rave Restaurant Group And 2 Other Promising US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2481963350","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481963350?lang=en_us&edition=full_marsco","pubTime":"2024-11-06 01:08","pubTimestamp":1730826497,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a rise, buoyed by gains in the technology sector and investor focus on the upcoming presidential election, attention is also drawn to smaller investment opportunities. Though often considered a relic from past trading days, \"penny stocks\" continue to represent potential for significant returns when they are backed by strong financials. This article will explore three such penny stocks that stand out for their balance sheet strength and growth potential in today's market landscape.Overview: Rave Restaurant Group, Inc. operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens under the Pizza Inn and Pie Five brands both in the United States and internationally, with a market cap of $42.96 million.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rave-restaurant-group-2-other-170817986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4551","RLX","STIM","BK4563","PHX","BK4139","BK4213","BK4075","BK4209","HLVX","RAVE","BK4526"],"gpt_icon":0},{"id":"2476297980","title":"BRIEF-HilleVax Completed Workforce Reduction Of About 15 Employees Constituting About 25% Of Co’S Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2476297980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476297980?lang=en_us&edition=full_marsco","pubTime":"2024-10-17 04:45","pubTimestamp":1729111554,"startTime":"0","endTime":"0","summary":"Oct 16 (Reuters) - Hillevax Inc   :   * HILLEVAX: COMPLETED WORKFORCE REDUCTION OF ABOUT 15 EMPLOYEES CONSTITUTING ABOUT 25% OF CO’S WORKFORCESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2476597673","title":"Hillevax: Completed Workforce Reduction of About 15 Employees Constituting About 25% of Co’s Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2476597673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476597673?lang=en_us&edition=full_marsco","pubTime":"2024-10-17 04:43","pubTimestamp":1729111390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nFWN3LS19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2475154193","title":"What Makes HilleVax (HLVX) a New Buy Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2475154193","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475154193?lang=en_us&edition=full_marsco","pubTime":"2024-10-15 00:00","pubTimestamp":1728921611,"startTime":"0","endTime":"0","summary":"HilleVax, Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for HilleVax basically reflects positivity about its earnings outlook that could translate into buying pressure and ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/makes-hillevax-hlvx-buy-stock-160011307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HLVX"],"gpt_icon":0},{"id":"2474093237","title":"How To Invest: Biotechs Can Make Huge Gains But Have Unique Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2474093237","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474093237?lang=en_us&edition=full_marsco","pubTime":"2024-10-11 20:00","pubTimestamp":1728648005,"startTime":"0","endTime":"0","summary":"In some cases, biotechs go public without having even a single product on the market.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2017/11/stock-biotech-05-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/11/stock-biotech-05-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/how-to-invest/investors-corner/how-to-invest-biotech-stock-risks/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4550","BK4007","BK4532","LU1571399168.USD","IE0002141913.USD","LU1061106388.HKD","BIB","LABU","LU2242652126.USD","LU0109394709.USD","LU0122379950.USD","LU1093756168.USD","IBB","AMGN","LU0058720904.USD","LU0889565916.HKD","LU0289739699.SGD","IE00BKVL7J92.USD","BK4534","LU1023059063.AUD","IE00BZ1G4Q59.USD","BK4501","LU0868494617.USD","IE00BFTCPJ56.SGD","HLVX","IE00B4R5TH58.HKD","BK4581","XBI","BK7104","BK4548","MRNA","IE0009355771.USD","LU0320765992.SGD","BNTX","LU1983299246.USD","LU2112291526.USD","BK4139","BK4551","LU1057294990.SGD","LU1093756325.SGD","FDN","BK4585","NVO.AU","IE00BJJMRZ35.SGD","LU2242646821.SGD","BK4533","LU0154236417.USD","NVO","IE00B2B36J28.USD","BK4568"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.hillevax.com","stockEarnings":[{"period":"1week","weight":-0.0536},{"period":"1month","weight":-0.1215},{"period":"3month","weight":-0.1804},{"period":"6month","weight":-0.0966},{"period":"1year","weight":-0.9044},{"period":"ytd","weight":-0.2319}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.047776},{"month":2,"riseRate":0.333333,"avgChangeRate":0.058295},{"month":3,"riseRate":0,"avgChangeRate":-0.07149},{"month":4,"riseRate":0,"avgChangeRate":-0.179654},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.11568},{"month":6,"riseRate":1,"avgChangeRate":0.102456},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.250361},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.073582},{"month":9,"riseRate":0.666667,"avgChangeRate":0.128117},{"month":10,"riseRate":0.666667,"avgChangeRate":0.032426},{"month":11,"riseRate":0.666667,"avgChangeRate":0.082705},{"month":12,"riseRate":0.666667,"avgChangeRate":0.026572}],"exchange":"NASDAQ","name":"HilleVax, Inc.","nameEN":"HilleVax, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HilleVax, Inc.(HLVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HilleVax, Inc.(HLVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HilleVax, Inc.,HLVX,HilleVax, Inc.股票,HilleVax, Inc.股票老虎,HilleVax, Inc.股票老虎国际,HilleVax, Inc.行情,HilleVax, Inc.股票行情,HilleVax, Inc.股价,HilleVax, Inc.股市,HilleVax, Inc.股票价格,HilleVax, Inc.股票交易,HilleVax, Inc.股票购买,HilleVax, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HilleVax, Inc.(HLVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HilleVax, Inc.(HLVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}